Recent Company News

• 04:05 PM ET Apr 30, 2025
  

  DBV Technologies reports Q1 EPS ($0.26) vs FactSet ($0.24) [1 est]; provides cash outlook (€1.59, 0.00)

• 04:24 AM ET Apr 24, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (49 total)

• 04:17 AM ET Apr 22, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (96 total)

• 05:21 AM ET Mar 24, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:17 AM ET Apr 02, 2025
  

  DBV Technologies upgraded to buy from hold at Portzamparc (pre-open) (€1.15, 0.00)

• 11:06 PM ET Mar 27, 2025
  

  DBV Technologies announces financing of up to $306.9M (€284.5M) to advance Viaskin Peanut Patch (€0.78, 0.00)

• 02:47 AM ET Mar 24, 2025
  

  DBV Technologies reports cash and cash equivalents at $32.5M as of 31-Dec-24; expects cash and cash equivalents will be sufficient to fund its operations only into April 2025 (€0.91, 0.00)

• 02:37 AM ET Mar 24, 2025
  

  FDA confirms safety exposure data generated from VITESSE Phase 3 clinical study and VITESSE Open-Label Extension sufficient to support BLA for Viaskin peanut patch in children 4 - 7-years-old (€0.91, 0.00)